Cormorant Asset Management’s PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) PVCT.WS Stock Holding History

Cormorant Asset Management’s Portfolio PVCT.WS Stock Details PVCT.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,200,000	Closed	-$114K	–	90
2016 Q3	$114K	Hold	2,200,000	–	–	0.01%	83
2016 Q2	$414K	Hold	2,200,000	–	–	0.06%	77
2016 Q1	$440K	Hold	2,200,000	–	–	0.07%	78
2015 Q4	$550K	Hold	2,200,000	–	–	0.07%	76
2015 Q3	$686K	Hold	2,200,000	–	–	0.11%	78
2015 Q2	$480K	Buy	+2,200,000	New	+$457K	0.06%	75

Cormorant Asset Management's PVCT.WS Position: Q4 2016 in Review

Cormorant Asset Management sold out of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) in Q4 2016, closing a stake of 2,200,000 shares — an estimated $114K sold.

Cormorant Asset Management first reported a position in PVCT.WS in Q2 2015 and held it in 6 quarters. The position peaked at $686K in Q3 2015. 0 funds tracked by Wall St. Rank hold PVCT.WS as of Q4 2016.

Cormorant Asset Management reported no remaining PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position as of Q4 2016 after selling out during the quarter.
Cormorant Asset Management sold 2,200,000 PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) shares in Q4 2016, an estimated $114K.
Cormorant Asset Management first reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in Q2 2015 and held it in 6 quarters.
Cormorant Asset Management's PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position peaked at $686K in Q3 2015.
0 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) as of Q4 2016.

Based on Cormorant Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.